{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:02:25Z","timestamp":1789902145340,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phrs.2026.108426","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:33:55Z","timestamp":1788190435000},"page":"108426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic syndrome identifies a high-risk polypharmacy phenotype in older adults with syncope"],"prefix":"10.1016","volume":"232","author":[{"given":"Susanna","family":"Longo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Fern\u00e1ndez-Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108426_bib1","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC Guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2026.108426_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2023.03.025","article-title":"Vasovagal syncope: An overview of pathophysiological mechanisms","volume":"112","author":"Longo","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.phrs.2026.108426_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pcad.2012.11.006","article-title":"Epidemiology of Syncope\/Collapse in Younger and Older Western Patient Populations","volume":"55","author":"Kenny","year":"2013","journal-title":"Progress. Cardiovasc. Dis."},{"key":"10.1016\/j.phrs.2026.108426_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12245-024-00708-z","article-title":"Evaluation of GFAP\/UCH-L1 biomarkers for computed tomography exclusion in mild traumatic brain injury (mTBI)","volume":"17","author":"Legramante","year":"2024","journal-title":"Int. J. Emerg. Med."},{"key":"10.1016\/j.phrs.2026.108426_bib5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.numecd.2019.11.016","article-title":"Diabetes influences cancer risk in patients with increased carotid atherosclerosis burden","volume":"30","author":"Rizza","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.phrs.2026.108426_bib6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12877-022-03388-7","article-title":"Correction: Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.phrs.2026.108426_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074892","article-title":"Deprescribing in older adults with polypharmacy","author":"Hung","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2026.108426_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/gerona\/glv219","article-title":"Medication Regimen Complexity and Number of Medications as Factors Associated With Unplanned Hospitalizations in Older People: A Population-based Cohort Study","volume":"71","author":"Wimmer","year":"2016","journal-title":"GERONA"},{"key":"10.1016\/j.phrs.2026.108426_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12877-023-04062-2","article-title":"Implications of the medication regimen complexity index score on hospital readmissions in elderly patients with heart failure: a retrospective cohort study","volume":"23","author":"Abdelbary","year":"2023","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.phrs.2026.108426_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2026.108426_bib11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.amjcard.2013.07.041","article-title":"Comparison of Incidence, Predictors, and the Impact of Co-Morbidity and Polypharmacy on the Risk of Recurrent Syncope in Patients <85 Versus \u226585 Years of Age","volume":"112","author":"Ruwald","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2026.108426_bib12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s40520-022-02165-1","article-title":"Prevalence and impact of polypharmacy in older patients with type 2 diabetes","volume":"34","author":"Remelli","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.phrs.2026.108426_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1479164120953625","article-title":"Risk of orthostatic hypotension associated with sodium-glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials","volume":"17","author":"Rong","year":"2020","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.phrs.2026.108426_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jash.2014.01.007","article-title":"Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis","volume":"8","author":"Baker","year":"2014","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.phrs.2026.108426_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pcd.2020.10.002","article-title":"Efficacy, renal safety and tolerability of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in elderly patients with type 2 diabetes: A real-world experience","volume":"15","author":"Tumminia","year":"2021","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.phrs.2026.108426_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/biomedicines12020264","article-title":"An Investigation of Metabolic Risk Factors and Gut Microbiota in Unexplained Syncope","volume":"12","author":"Longo","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108426_bib17","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.3390\/biomedicines12112641","article-title":"A Metabolomic Approach to Unexplained Syncope","volume":"12","author":"Longo","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108426_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.phrs.2026.108426_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.phrs.2026.108426_bib20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development and Validation of the Medication Regimen Complexity Index","volume":"38","author":"George","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2026.108426_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40266-020-00796-5","article-title":"Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications","volume":"37","author":"Rivasi","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.phrs.2026.108426_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.15441\/ceem.17.261","article-title":"Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department","volume":"5","author":"Lee","year":"2018","journal-title":"Clin. Exp. Emerg. Med."},{"key":"10.1016\/j.phrs.2026.108426_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112341","article-title":"Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life","volume":"144","author":"Rizza","year":"2021","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.phrs.2026.108426_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.70311","article-title":"Perspectives of Older Patients on the Complexity of Medication Use","author":"Falke","year":"2026","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.phrs.2026.108426_bib25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/europace\/eus154","article-title":"The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study","volume":"14","author":"Ruwald","year":"2012","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.phrs.2026.108426_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s40618-022-02002-2","article-title":"DARWIN-FUP network. Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study","volume":"46","author":"Morieri","year":"2023","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.phrs.2026.108426_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105052","article-title":"Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists","volume":"160","author":"Berra","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108426_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106396","article-title":"SGLT2-inhibitors are effective and safe in the elderly: The SOLD study","volume":"183","author":"Lunati","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108426_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107517","article-title":"Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study","volume":"210","author":"Berra","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108426_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4093\/dmj.2018.0259","article-title":"Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet","volume":"43","author":"Spallone","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.phrs.2026.108426_bib31","unstructured":"Corrigendum to: 2018 ESC\/ESH Guidelines for the management of arterial hypertension 40 Eur. Heart J. 4752019, 47510.1093\/eurheartj\/ehy686."},{"key":"10.1016\/j.phrs.2026.108426_bib32","unstructured":"Correction: New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope 107 Heart e132021, e1310.1136\/heartjnl-2020-318261corr1."},{"key":"10.1016\/j.phrs.2026.108426_bib33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/heartjnl-2016-309865","article-title":"Stop vasodepressor drugs in reflex syncope: a randomised controlled trial","volume":"103","author":"Solari","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2026.108426_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ageing\/afv199","article-title":"Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden","volume":"45","author":"Moonen","year":"2016","journal-title":"Age Ageing"},{"key":"10.1016\/j.phrs.2026.108426_bib35","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/bcp.16113","article-title":"The prevalence of polypharmacy in older Europeans: A multi-national database study of general practitioner prescribing","volume":"90","author":"Bennie","year":"2024","journal-title":"Brit J. Clin. Pharma"},{"issue":"1","key":"10.1016\/j.phrs.2026.108426_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11892-026-01623-8","article-title":"Dysregulation of the gut-adipose tissue-liver axis: a possible mechanism behind the relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes","volume":"26","author":"Longo","year":"2026","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.phrs.2026.108426_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108032","article-title":"Glycometabolic cardiac dysfunction in HFpEF: Lessons from multi-omics studies","volume":"222","author":"Longo","year":"2025","journal-title":"Pharmacol. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:50:41Z","timestamp":1789901441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S1043661826003415"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108426","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome identifies a high-risk polypharmacy phenotype in older adults with syncope","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108426"}}